Cargando…

Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study

OBJECTIVES: Giant cell arteritis (GCA) is a chronic systemic vasculitis of large and medium-sized arteries, for which long-term glucocorticoid (GC) treatment is needed. During GC withdrawal patients can suffer adrenal insufficiency. We sought to determine the time until recovery of adrenal function...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jamilloux, Yvan, Liozon, Eric, Pugnet, Gregory, Nadalon, Sylvie, Heang Ly, Kim, Dumonteil, Stephanie, Gondran, Guillaume, Fauchais, Anne-Laure, Vidal, Elisabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3722149/ https://www.ncbi.nlm.nih.gov/pubmed/23894335 http://dx.doi.org/10.1371/journal.pone.0068713

Ejemplares similares

Correction: Recovery of Adrenal Function after Long-Term Glucocorticoid Therapy for Giant Cell Arteritis: A Cohort Study
por: Jamilloux, Yvan, et al.
Publicado: (2013)

Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients
por: Ly, Kim Heang, et al.
Publicado: (2016)

Characteristics and Clinical Value of 18F-FDG PET/CT in the Management of Adult-Onset Still’s Disease: 35 Cases
por: Brisset, Josselin, et al.
Publicado: (2021)

Use of high-plex data provides novel insights into the temporal artery processes of giant cell arteritis
por: Parreau, Simon, et al.
Publicado: (2023)

Immune-Mediated Diseases Following COVID-19 Vaccination: Report of a Teaching Hospital-Based Case-Series
por: Liozon, Eric, et al.
Publicado: (2022)

Neurotrophins are expressed in giant cell arteritis lesions and may contribute to vascular remodeling
por: Ly, Kim Heang, et al.
Publicado: (2014)

Morphée à la suite d’une vaccination anti-COVID-19
por: Teamotuaitau, M., et al.
Publicado: (2023)

Giant-cell arteritis without cranial manifestations: Working diagnosis of a distinct disease pattern
por: de Boysson, Hubert, et al.
Publicado: (2016)

Improvement of Treg immune response after treatment with tocilizumab in giant cell arteritis
por: Samson, Maxime, et al.
Publicado: (2021)

The effect of clinical features and glucocorticoids on biopsy findings in giant cell arteritis
por: Jakobsson, Karin, et al.
Publicado: (2016)

Stratified glucocorticoid monotherapy is safe and effective for most cases of giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

Recovery of Adrenal Function in Patients with Glucocorticoids Induced Secondary Adrenal Insufficiency
por: Baek, Jong Ha, et al.
Publicado: (2016)

Diagnostic Value of 18F-FDG PET/CT vs. Chest-Abdomen-Pelvis CT Scan in Management of Patients with Fever of Unknown Origin, Inflammation of Unknown Origin or Episodic Fever of Unknown Origin: A Comparative Multicentre Prospective Study
por: Ly, Kim-Heang, et al.
Publicado: (2022)

Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis
por: Smutny, Tomas, et al.
Publicado: (2019)

Healthcare Costs of Potential Glucocorticoid-Associated Adverse Events in Patients with Giant Cell Arteritis
por: Best, Jennie H, et al.
Publicado: (2019)

Validity of Machine Learning in Predicting Giant Cell Arteritis Flare After Glucocorticoids Tapering
por: Venerito, Vincenzo, et al.
Publicado: (2022)

Serum Neurotrophin Profile in Systemic Sclerosis
por: Lise, Marie-Claude, et al.
Publicado: (2010)

Glucocorticoid Effects on Tissue Residing Immune Cells in Giant Cell Arteritis: Importance of GM-CSF
por: Wagner, Annette D., et al.
Publicado: (2021)

Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab
por: Stone, John H., et al.
Publicado: (2019)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort
por: Esen, Idil, et al.
Publicado: (2023)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

(18)F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis: A multicenter cohort of 130 patients
por: de Boysson, Hubert, et al.
Publicado: (2016)

A qualitative study of patient perspectives related to glucocorticoid therapy in polymyalgia rheumatica and giant cell arteritis
por: Hoon, Elizabeth, et al.
Publicado: (2019)

Impact of Glucocorticoid Cumulative Doses in a Real-Life Cohort of Patients Affected by Giant Cell Arteritis
por: Castan, Paul, et al.
Publicado: (2022)

Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study
por: Mensch, Noemi, et al.
Publicado: (2023)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

From Active to Non-active Giant Cell Arteritis: Longitudinal Monitoring of Patients on Glucocorticoid Therapy in Combination With Leflunomide
por: Kuret, Tadeja, et al.
Publicado: (2022)

Bone mineral density in patients diagnosed with giant cell arteritis taking glucocorticoids: a case–control study
por: Geressu, Adam, et al.
Publicado: (2023)

Decreased Immunity to Varicella Zoster Virus in Giant Cell Arteritis
por: Rondaan, Christien, et al.
Publicado: (2017)

Colour Doppler ultrasound and the giant cell arteritis probability score for the diagnosis of giant cell arteritis: a Canadian single-centre experience
por: Zarka, Farah, et al.
Publicado: (2021)

Serum and Lymphocytic Neurotrophins Profiles in Systemic Lupus Erythematosus: a Case-Control Study
por: Fauchais, Anne-Laure, et al.
Publicado: (2013)

Baseline Glucocorticoid‐Related Toxicity Scores in Giant Cell Arteritis: A Post Hoc Analysis of the GiACTA Trial
por: Patel, Naomi J., et al.
Publicado: (2023)

Involvement of Monocyte Subsets in the Immunopathology of Giant Cell Arteritis
por: van Sleen, Yannick, et al.
Publicado: (2017)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_brfted7lspo001tkkhqot5v92g